Case Report
Memantine as an Augmentation Therapy for Anxiety Disorders
Table 1
Demographic and clinical characteristics of patients.
| | Mean | Range |
| Age | 44 years | 26–63 years |
| | Number | (%) |
| Gender | | | Females | 11 | (74%) | Males | 4 | (26%) | Diagnosis | | | Generalized anxiety disorder | 15 | (100%) | Comorbid social anxiety disorder | 4 | (26%) | Medications at time of enrollment | | | Selective serotonin re-uptake inhibitor (SSRI) | 15 | (100%) |
|
|